[Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines]

Area of Science:

• Virology
• Oncology
• Immunology

Background:

• Metastatic melanoma remains a significant challenge in cancer treatment.
• Oncolytic viruses are emerging as a promising therapeutic strategy.
• The Leningrad-3 (L-3) strain of mumps virus (MV) is an attenuated vaccine strain with potential oncolytic properties.

Purpose of the Study:

• To evaluate the oncolytic potential of the MV L-3 strain against human metastatic melanoma cell lines.
• To investigate the susceptibility and permissiveness of melanoma cells to MV infection.
• To explore the mechanisms underlying the selective oncolytic activity of MV L-3.

Main Methods:

• In vitro evaluation of MV L-3 infection in four human metastatic melanoma cell lines.
• Assessment of MV replication efficiency and induction of cell death.
• Analysis of type I interferon gene expression patterns in response to MV infection.

Main Results:

• Melanoma cell lines were susceptible and permissive to MV L-3 infection.
• Efficient MV replication resulted in melanoma cell death, with varying effects across cell lines.
• Oncolytic activity correlated with type I interferon gene expression patterns.
• Melanoma cell lines did not exhibit induction of the full spectrum of antiviral genes.

Conclusions:

• The MV L-3 strain demonstrates oncolytic potential against human melanoma cells.
• The selectivity and efficacy of MV L-3 are influenced by type I interferon gene expression.
• MV L-3 is a promising candidate for oncolytic virotherapy in melanoma.